Positive psychotherapy for psychosis in Hong Kong: A randomized controlled trial.

Postive Psychotherapy Psychosis Randomized controlled trial Recovery Well-being

Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
02 2022
Historique:
received: 22 04 2021
revised: 21 11 2021
accepted: 25 12 2021
pubmed: 15 1 2022
medline: 29 3 2022
entrez: 14 1 2022
Statut: ppublish

Résumé

Recovery-oriented practice has been advocated in mental health services in Hong Kong since 2009. Well-being has become an important area of focus for mental health services. Positive Psychotherapy for Psychosis (PPP) is a well-being-focused intervention for use in psychosis, with preliminary evidence from a randomized controlled trial in the United Kingdom of impact on well-being and symptomatology. The aim of this study was to test the effectiveness of PPP on the well-being of people with psychosis in Hong Kong. The study was a randomized controlled trial with two-arm parallel groups. Both groups received treatments as usual, and in addition the intervention group received a 13-session intervention based on a Cantonese Chinese translation of the PPP manual. Intention-to-treat analysis was used. The trial was registered (ANZCTR: ACTRN12620000464965). A total of 154 participants (78 intervention, 76 control) were recruited. As compared to control group, intervention group participants showed significant changes over time on the primary outcome of well-being assessed using the Chinese Short Warwick-Edinburgh Mental Well-being Scale (p = 0.001) and on secondary outcomes of hope (Agency subscale: p = 0.029) and self-efficacy (p = 0.001). Positive Psychotherapy for Psychosis was found to be an effective treatment in improving the well-being and other mental health outcomes for people with psychosis. It can be recommended for use in mental health services to promote recovery.

Identifiants

pubmed: 35030447
pii: S0920-9964(21)00528-4
doi: 10.1016/j.schres.2021.12.044
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-183

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Menza Hon-Wai Chu (MH)

Occupational Therapy Department, Kwai Chung Hospital, Hong Kong, People's Republic of China. Electronic address: chuhw@ha.org.hk.

Bien Lau (B)

Occupational Therapy Department, Kwai Chung Hospital, Hong Kong, People's Republic of China.

Joey Leung (J)

Department of Psychiatry, Kwai Chung Hospital, Hong Kong, People's Republic of China.

Sheung Chun Chan (SC)

Department of Psychiatry, Kwai Chung Hospital, Hong Kong, People's Republic of China.

Betty Tang (B)

Occupational Therapy Department, Kwai Chung Hospital, Hong Kong, People's Republic of China.

Charles Lau (C)

Occupational Therapy Department, Kwai Chung Hospital, Hong Kong, People's Republic of China.

Christopher Newby (C)

School of Medicine, University of Nottingham, United Kingdom.

Rose Chiu (R)

Occupational Therapy Department, Kwai Chung Hospital, Hong Kong, People's Republic of China.

William Tak-Lam Lo (WT)

Department of Psychiatry, Kwai Chung Hospital, Hong Kong, People's Republic of China.

Beate Schrank (B)

Karl Landsteiner University of Health Sciences, Department of Psychiatry, Krems, Austria.

Mike Slade (M)

School of Health Sciences, Institute of Mental Health, University of Nottingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH